脑功能核磁共振成像在精神疾病中的应用

摘要/Abstract

摘要：

主要介绍了几种脑功能核磁共振成像方法以及在精神疾病中的研究情况.血氧水平依赖fMRI (BOLD-fMRI)是目前应用最广泛的fMRI技术，可利用神经激活后对局部血流的影响，间接显示神经活动.灌注加权成像是直接测定脑血流的fMRI技术，但由于它的时间分辨率比较低，对快速的脑功能难以进行研究.扩散加权象目前主要用于脑缺血的早期诊断，利用该技术也可示踪神经通路.化学位移成像能够检测局部组织代谢产物的含量，可反映不同脑区能量和物质代谢的状况，也是一种脑功能的研究手段.尽管这些技术在神经、心理学领域已经取得非常可喜的进展，目前fMRI在精神疾病方面的工作较少，相信随着技术的改进，fMRI必将在精神疾病方面大显身手.

关键词: 功能核磁共振成像, BOLD效应, 精神疾病, 脑功能

Abstract:

Magnetic Resonance Imaging(MRI) of the brain is well-recognized for its excellent spatial resolution, allowing neuroantomic structures to be viewed in sharp detail. Recently, it has become possible to modify a conventional MRI scanner to study the brain's function as well. This new technique, called functional Magnetic Resonance Imaging (fMRI), has excited brain-researchers for its several good features. The most commonly used fMRI technique is BOLDfMRI (

Blood-Oxygen-Level-Dependent-fMRI). It is based on the principle that when abrain region is being used, arterial oxygenated blood will redistribute and increase to this area. Perfusion fMRI which can measure absolute regional blood flow has some limitations in that it takes several minutes to acquire information on a single slice of interest. It would be tedious obtainto enough images on this slice within a single session to make a statistical statement on a given subject. Diffusion-weight Imaging is used to diagnosis the early post-storke and to detecte the direction of myelin fibers tracts. MRI spectroscopy, an old fMRI technique, offers the capability of using MRI to noninvasively study tissue biochemistry which can determine the level of substance or energy metabolism. These techniques have been used widespreadly in neurology and neurosurgery. While there are currently no clinical indications for ordering any of these fMRI techniques, they hold considerable promise for unraveling the neurocircuitry and metabolic pathways of psychiatric disorders in the immediate future and in helping in psychiatric diagnosis and treatment planning down the road.

Key words:

Functional Magnetic Resonance Imaging, BOLD effect, Psychiatric disease, Brain function

中图分类号:

O482.53++2

孙学军，李丽云，刘买利，叶朝辉. 脑功能核磁共振成像在精神疾病中的应用[J]. 波谱学杂志.

参考文献

[1] Posse S, Muller-Gartner H W, Dager S R. Functional Magnetic Resonance Studies of Brain Activation. Seminars in Clinical[J]. Neuropsychiatry, 1996, 1:76-88

[2] Binder J R, Swanson S J, Hammeke T A, Morris GL, Mueller WM, Fischer M, et al. Determination of language dominance. using functional MRI: A comparison with the Wada test[J]. Neurol, 1996; 46:978-984

[3] Binder J R. Neuroanatomy of Language Processing Studies with Functional MRI. Clinical Neuroscience, 1997, 4:87-94

[4] Bookheimer S Y. Functional MRI Applications in Clinical Epilepsy[J]. Neuroimage, 1996, 4:S139-S146

[5] Jack C R, Thompson R M, Butts R K, Sharbrough F W, Kelly P J, Hanson D P, et al. Sensory Motor Cortex: Correlation of Presurgical Mapping with Functional MR Imaging and Invasive Cortical Mapping[J]. Radiology, 1994, 190:85-92

[6] Moseley M E, deCrespigny A, Spielman D M. Magnetic Resonance Imaging of Human Brain Function\[J\]. Surgical Neurology, 1996, 45:385-391

[7] Thulborn K R, Waterton J C, Matthews P M, Radda G K. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field[J]. Biochem Biophys Acta, 1982, 714:265-270

[8] Turner R, Le Bihan D, Moonen C T, Despres D, Frank J. Echo-planar time course MRI of cat brain oxygenation changes\[J\]. Magn Reson Med, 1991, 22:159-166

[9] David A, Blamire A, Breiter H. Functional Magnetic Resonance Imaging: A new technique with implications for psychology and psychiatry\[J\]. Brit J Psychiatry, 1994, 164:2-7

[10] George M S, Ketter T A, Kimbrell T A, Speer A M, Lorberbaum J, L iberatos C C, et al. Neuroimaging Approaches to the Study of Emotion. In: Borod J, editor. The Neuropsychology of Emotion[M]. New York: Oxford University Press, 1998:IN PRESS

[11] Menon R S, Ogawa S, Hu X, Strupp J P, Anderson P, Ugurbil K. BOLD based functional MRI at 4 Tesla includes a capillary bed contribution: echo-planar imaging correlates with previous optical imaging using intrinsic signals[J]. Magn Res Med, 1995, 33:453-459

[12] Breiter H C, Rauch S L, Kwong K K, Baker J R, Weisskoff R M, Kennedy D N, et al. Functional Magnetic Resonance Imaging of Symptom Provocation in obsessive-compulsive disorder[J]. Arch Gen Psychiatry, 1996, 53:595-606

[13] George M S, Ketter T A, Post R M. What Functional Imaging Studies Have RevealedAbout the Brain Basis of Mood and Emotion. In: Panksepp J, editor. Advances in Biological Psychiatry. Greenwich, Conn. JAI Press, 1996, 63-113

[14] George M S, Post R M, Ketter T A, Kimbrell T A. Neural Mechanisms of Mood Disorders. In: Rush A J, editor. Current Review of Mood Disorders. Philadelphia: Current MEdicine, 1995,1 

[15] Whalen P J, Rauch S L, Etcoff N L, McInerney S C, Lee M B, Jenike M A. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge[J]. The J Neuroscience, 1998, 18:411-418

[16] Breiter H C, Etcoff N L, Whalen P J, Kennedy W A, Rauch S L, Buckner R L, et al. Response and habituation of the human amygdala during visual processing of facial

expression[J]. Neuron, 1996, 17:875-887

[17] Belliveau J W, Kennedy D N, McKinstry R C, Buchbinder B R, Weisskoff R M, Cohen M S, et al. Functional mapping of the human visual cortex by magnetic resonance imaging[J]. Science, 1991, 254:716719

[18] Rosen B R, Belliveau J W, Aronen H J, Kennedy D, Buchbinder B R, Fischman A, et al. Susceptibility contrast imaging of cerebral blood volume: human experience[J]. Magn Reson Med, 1991, 22:293-9; discuss

[19] Harris G J, Lewis R F, Satlin A, English C D, Scott T M, Yurgelun-Todd D A, et al. Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease[J]. Am J Psychiatry, 1996, 153:721-724

[20] Villringer A, Rosen B R, Belliveau J W, Ackerman J L, Lauffer R B, Buxton R B, et al. Dynamic imaging with lanthimide chelates in normal brain: contrast due to magnetic susceptibility effects[J]. Magn Res Med, 1988, 6:164-174

[21] Warach S, Sievert B, Darby D, Thangaraj V, Edelman R. EPISTAR perfusion echo-planar imaging of human brain tumors[J]. J MRI, 1994, 4:S8

[22] Edelman R R, Siewert B, Darby D G, Thangaraj V, Nobre A C, Mesulam M M, et al. Qualitative mapping of cerebral blood flow and functional localization with ech-planar MR imaging and signal targeting with alternating radio frequency[J]. Radiology, 1994, 192:513-520

[23] Roberts D A, Detre J A, Bolinger L, Insko E K, Leigh J S. Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady state inversion of arterial water[J]. Proc Natl Acad Sci USA, 1994, 91:33-37

[24] Williams D S, Detre J A, Leigh J S, Koretsky A P. Magnetic resonance imaging of perfusion using spin inversion of arterial water\[J\]. Proc Natl Acad Sci USA, 1992, 89:212-216

[25] Speer A M, Upadhyaya V H, Bohning D E, Risch S C, Vincent D J, George M S. New Windows into Bipolar Illness: Serial Perfusion MRI Scanning in Rapid-Cycling Bipolar Patients[J]. APA New Research Abstracts, 1997, 111 Abstract

[26] Fisher M, Prichard J W, Warach S. New magnetic resonance techniques for acute ischemic stroke[J]. JAMA, 1995, 274:908-911

[27] Sakuma H, Nomura Y, Takeda K, Tagami T, Nakagawa T, Tamagawa Y, et al. Adult and neonatal human brain: diffusional anisotropy and myelination with diffusion-weighted MR imaging[J]. Radiology, 1991, 180:229-233

[28] Lutsep H L, Albers G W, deCrespigny A, Kamat G N, Marks M P, Moseley M E. Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke[J]. Ann Neurol, 1997, 41:574-580

[29] Koroshetz W J, Gonzalez G. Diffusionweighted MRI: an ECG for “brain attack”[J]? Ann Neurol, 1997, 41:565-566

[30] Zivan J A. Diffusionweighted MRI for diagnosis and treatment of ischemic stroke\[J\]. Ann Neurol, 1997, 41:567-568

[31] Moore C M, Renshaw P F. Magnetic Resonance Spectroscopy Studies of Affective Disorders. In: Krishnan K R R, Doraiswarmy P M, editors. Brain Imaging in Clinical Psychiatry\[M\]. New York: Marcel-Dekker, 1997,185-213

[32] Frangou S, Williams S C. Magnetic resonance spectroscopy in psychiatry: basic principles and applications\[J\]. British Medical Bulletin, 1996, 52:474-485

[33] Posse S, Dager S R, Richards T L, Yuan C, Ogg R, Artru A A, et al. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echoplanar spectroscopic imaging (PEPSI)[J]. Magn Res Med, 1997, 37:858-865

[34] Duncan J S. Imaging and epilepsy\[J\]. Brain, 1997, 120:339-377

[35] Ketter T A, George M S, Kimbrell T A, Benson B A, Post R M. Functional brain imaging in mood and anxiety disorders\[J\]. Current Review of Mood and Anxiety Disorders, 1997, 1:96-112

[36] Pettegrew J W, Withers G, Panchalingam K, Post J F. ³¹P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's Disease[J]. J Neural Transm Suppl, 1987, 24:261-268

[37] Pettegrew J W, Panchalingam K, Withers G, McKeag D, Strychor S. Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat[J]. J Neuropathol Exp Neurol, 1990, 49:237-249

[38] Pettegrew J W, Panchalingam K, Moossy J, Martinez J, Rao G, Boller F. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologica findings in Alzheimer's disease[J]. Arch Neurol, 1988, 45:1093-1096

[39] Miller B L, Moats R A, Shonk T, Ernst T, Woolley S, Ross B D. Alzheimer Disease: depiction of increased cerebral myoinositol with proton MR spectroscopy[J]. Radiology, 1993, 187:433-437

[40] Shonk T K, Moats R A, Gifford P, Michaelis T, Mandigo J C, Izumi J, et al. Probable Alzheimer disease: diagnosis with MR spectroscopy\[J\]. Radiology, 1995, 195:65-72